LAG3 and COVID-19: Several studies report sustained T cell activation in PCC following severe COVID-19 (6–8) and indeed, hospitalized cases in our study had higher levels of all examined T cell markers (i.e., sCD25, sTIM-3 and sLAG-3) up to 12 months post-infection as compared with home-isolated patients.